FDA Approves Aducanumab for Alzheimer’s Disease: An Unethical Decision?
FDA’s approval of aducanumab may run against the bioethical principles of beneficence and non-maleficence.
dementia care
-
Read more: FDA Approves Aducanumab for Alzheimer’s Disease: An Unethical Decision? -
Read more: Aducanumab: A Bitter Pill to Swallow Aducanumab: A Bitter Pill to Swallow
Patients are understandably desperate, but their needs are best served by following the science, rather than lowering the standards for drugs.
-
Read more: COVID-19 and Dementia Care: Lessons for the Future COVID-19 and Dementia Care: Lessons for the Future
Family caregivers hold a critical role in the health care system and the economy, but do not receive adequate support and recognition.
